PA Licensure Compact Commission Holds First Official Meeting

The PA Licensure Compact Commission held its first official meeting, advancing the pathway for PAs to practice across state lines. Delegates voted on bylaws, elected an executive committee, and discussed critical elements for the compact's operational framework.

AAPA: SCOTUS Mifepristone Ruling Protects PAs’ Prescribing Rights

The American Academy of Physician Associates (AAPA), released the following statement, on the Supreme Court of the United States’ (SCOTUS) decision to overturn a Fifth Circuit ruling that placed restrictions on mifepristone, including stripping away PA prescribing rights. 

New Federal Rule Allows PAs at OTPs to Order Methadone

On February 2, SAMHSA and HHS issued a new final rule that changes the definition of providers who are able to order the dispensing of methadone at opioid treatment programs, consistent with DEA licensing and state law, to include PAs at opioid treatment programs.

AAPA Comments on the Proposed 2024 Medicare Physician Fee Schedule

The American Academy of PAs (AAPA) submitted comments to the Centers for Medicare and Medicaid Services (CMS), the federal agency that oversees the Medicare program, in response to the 2024 Physician Fee Schedule (PFS) proposed rule. The rule recommends numerous changes to Medicare’s coverage and payment policies that impact PAs, physicians and other health professionals.